-
1 Comment
Accolade, Inc is currently in a long term uptrend where the price is trading 15.5% above its 200 day moving average.
From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 16.6.
Based on the above factors, Accolade, Inc gets an overall score of 2/5.
CurrencyCode | USD |
---|---|
Exchange | NASDAQ |
Industry | Health Information Services |
Sector | Healthcare |
ISIN | US00437E1029 |
Dividend Yield | 0.0% |
---|---|
Market Cap | 1B |
Target Price | 14.41 |
PE Ratio | None |
Beta | 1.62 |
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ACCD using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024